Alternatives to Code Ocean

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered blood test for early cancer detection and subtyping.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Develops a computational model of the human body for drug discovery and development.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

EU-based company providing personalized medicine solutions for medical practitioners.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

AI-powered platform for designing novel molecular structures for new medicines.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Developing novel therapeutic approaches for ocular diseases.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Specialized services for pharmaceutical and life sciences clients across product development and commercialization.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Unleashing the power of genomics at scale for biological advances and human health.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

AI-enabled technology for cell biology research and biopharma development.

AI-driven digital twin of embryo development for cell-based therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing novel therapeutics for rare genetic diseases.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.